Background: The TST trial (Treat Stroke to Target) showed the benefit of targeting a low-density lipoprotein cholesterol (LDL-C) concentration of <70 mg/dL in terms of reducing the risk of major ca...
BackgroundWe aimed to correlate alterations in the rat sarcoma virus (RAS)/mitogen‐activated protein kinase pathway in vascular anomalies to the clinical phenotype for improved patient and…
The recurrence rate of ischemic stroke remains substantial despite advances in secondary prevention, reaching 5 to 8% at three months in recent clinical trials. 1-4…
, Department of Cardiology, , Radboud University Medical Center, , Nijmegen, , the Netherlands,, Department of Internal Medicine, , Radboud University Medical Center, , Nijmegen,…
BackgroundIn 2009, a workplace‐based hypertension management program was launched among men with hypertension in the Kailuan study. This program involved monitoring blood pressure semimonthly, prov…
Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their…
Correspondence to: Jenelle A. Jindal, MD, Center for Biomedical Informatics Research, Stanford University, Stanford, CA 94305. Email Center for Biomedical Informatics Research, Stanford University, CA.…
Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their…
Department of Cardiology, University Medical Center Hamburg-Eppendorf, Germany (M.N.). Correspondence to: Vivek Y. Reddy, MD, Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, Department of…
BackgroundExtended sedentary behavior is a risk factor for chronic disease and mortality, even among those who exercise regularly. Given the time constraints of incorporating physical…
Correspondence to: Rishi K. Wadhera, MD, MPP, MPhil, Section of Health Policy and Equity at the Richard A. and Susan F. Smith Center for Outcomes…
